| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.047 | 0.8 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.04 | 0.8 |